UK Markets closed

Envista Holdings Corporation (NVST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
34.82-0.38 (-1.08%)
At close: 04:00PM EST
34.82 +0.01 (+0.03%)
After hours: 04:08PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.52
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 352.03
52-week low 331.67
50-day moving average 334.56
200-day moving average 339.97

Share statistics

Avg vol (3-month) 31.81M
Avg vol (10-day) 31.63M
Shares outstanding 5161.37M
Implied shares outstanding 6N/A
Float 8162.67M
% held by insiders 10.21%
% held by institutions 1117.24%
Shares short (13 Oct 2022) 411.37M
Short ratio (13 Oct 2022) 46
Short % of float (13 Oct 2022) 49.31%
Short % of shares outstanding (13 Oct 2022) 46.96%
Shares short (prior month 14 Sept 2022) 411.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 11.86%
Operating margin (ttm)14.81%

Management effectiveness

Return on assets (ttm)3.63%
Return on equity (ttm)6.03%

Income statement

Revenue (ttm)2.54B
Revenue per share (ttm)15.65
Quarterly revenue growth (yoy)1.30%
Gross profit (ttm)1.47B
EBITDA 503.6M
Net income avi to common (ttm)237.6M
Diluted EPS (ttm)2.04
Quarterly earnings growth (yoy)-47.70%

Balance sheet

Total cash (mrq)523.1M
Total cash per share (mrq)3.2
Total debt (mrq)1.52B
Total debt/equity (mrq)37.85
Current ratio (mrq)1.11
Book value per share (mrq)24.47

Cash flow statement

Operating cash flow (ttm)250M
Levered free cash flow (ttm)243.34M